Global Blood Therapeutics (GBT) Reports Q2 LPS of $0.58
Tweet
Share
E-mailGet Alerts GBT Hot Sheet
Price: $68.49 --0%
Financial Fact:
Weighted average number of common shares outstanding - basic: 76.44M
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Weighted average number of common shares outstanding - basic: 76.44M
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Global Blood Therapeutics (NASDAQ: GBT) reported Q2 EPS of ($0.58), versus ($4.84) reported last year.
Cash and cash equivalents totaled $231.9 million at June 30, 2016 compared with $148.5 million at December 31, 2015.
For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
